| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.47e-10 | 26 | 30 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium ion binding | 4.10e-09 | 14 | 30 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.33e-08 | 52 | 30 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 6.05e-08 | 26 | 30 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.20e-06 | 171 | 30 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.45e-04 | 343 | 30 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.57e-04 | 459 | 30 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 5.90e-04 | 465 | 30 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | channel activity | 1.02e-03 | 525 | 30 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.03e-03 | 526 | 30 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.23e-03 | 627 | 30 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | integrin binding | 2.26e-03 | 175 | 30 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.86e-03 | 664 | 30 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.04e-03 | 758 | 30 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 6.09e-03 | 793 | 30 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | phosphatase binding | 7.13e-03 | 264 | 30 | 3 | GO:0019902 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 7.34e-03 | 1180 | 30 | 6 | GO:0022857 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.36e-09 | 36 | 32 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 3.94e-08 | 62 | 32 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 4.27e-08 | 63 | 32 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.19e-07 | 87 | 32 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 3.06e-07 | 93 | 32 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 7.73e-07 | 112 | 32 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.13e-06 | 121 | 32 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.44e-06 | 127 | 32 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.60e-06 | 153 | 32 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 5.53e-06 | 167 | 32 | 5 | GO:0060048 | |
| GeneOntologyBiologicalProcess | action potential | 1.36e-05 | 201 | 32 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.60e-05 | 208 | 32 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 1.93e-05 | 559 | 32 | 7 | GO:0042391 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.97e-05 | 217 | 32 | 5 | GO:0006941 | |
| GeneOntologyBiologicalProcess | muscle contraction | 3.03e-05 | 400 | 32 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 5.78e-05 | 912 | 32 | 8 | GO:0030029 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 6.09e-05 | 275 | 32 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | response to toxic substance | 7.70e-05 | 289 | 32 | 5 | GO:0009636 | |
| GeneOntologyBiologicalProcess | heart contraction | 8.90e-05 | 298 | 32 | 5 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 1.06e-04 | 309 | 32 | 5 | GO:0003015 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.70e-04 | 547 | 32 | 6 | GO:0003012 | |
| GeneOntologyBiologicalProcess | blood circulation | 4.24e-04 | 648 | 32 | 6 | GO:0008015 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 4.40e-04 | 922 | 32 | 7 | GO:0098662 | |
| GeneOntologyBiologicalProcess | positive regulation of protein depolymerization | 4.81e-04 | 21 | 32 | 2 | GO:1901881 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 4.82e-04 | 238 | 32 | 4 | GO:0050954 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 5.00e-04 | 942 | 32 | 7 | GO:0098655 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 5.71e-04 | 105 | 32 | 3 | GO:1901879 | |
| GeneOntologyBiologicalProcess | metal ion transport | 7.15e-04 | 1000 | 32 | 7 | GO:0030001 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 7.90e-04 | 1017 | 32 | 7 | GO:0098660 | |
| GeneOntologyBiologicalProcess | circulatory system process | 8.11e-04 | 733 | 32 | 6 | GO:0003013 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 1.12e-03 | 32 | 32 | 2 | GO:0048266 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 1.35e-03 | 1115 | 32 | 7 | GO:0034220 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.43e-03 | 144 | 32 | 3 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.43e-03 | 144 | 32 | 3 | GO:0043244 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 1.68e-03 | 1157 | 32 | 7 | GO:0006812 | |
| GeneOntologyBiologicalProcess | positive regulation of protein-containing complex disassembly | 1.84e-03 | 41 | 32 | 2 | GO:0043243 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 2.02e-03 | 43 | 32 | 2 | GO:0062149 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 4.36e-11 | 17 | 33 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 8.25e-10 | 29 | 33 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 3.16e-05 | 235 | 33 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | axon | 5.67e-05 | 891 | 33 | 8 | GO:0030424 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.86e-04 | 785 | 33 | 7 | GO:0098797 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.95e-04 | 378 | 33 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | main axon | 3.71e-04 | 89 | 33 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | node of Ranvier | 4.51e-04 | 20 | 33 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | sarcomere | 6.13e-04 | 249 | 33 | 4 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 8.64e-04 | 273 | 33 | 4 | GO:0030016 | |
| GeneOntologyCellularComponent | axon initial segment | 9.55e-04 | 29 | 33 | 2 | GO:0043194 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.08e-03 | 290 | 33 | 4 | GO:0043292 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.28e-03 | 523 | 33 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 1.60e-03 | 550 | 33 | 5 | GO:1990351 | |
| GeneOntologyCellularComponent | Z disc | 1.72e-03 | 151 | 33 | 3 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 2.25e-03 | 166 | 33 | 3 | GO:0031674 | |
| HumanPheno | Clonic seizure | 6.52e-07 | 81 | 12 | 5 | HP:0020221 | |
| HumanPheno | Complex febrile seizure | 5.50e-06 | 16 | 12 | 3 | HP:0011172 | |
| HumanPheno | Infection-related seizure | 1.18e-05 | 145 | 12 | 5 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 1.18e-05 | 145 | 12 | 5 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 1.18e-05 | 145 | 12 | 5 | HP:0002373 | |
| HumanPheno | Multifocal epileptiform discharges | 1.18e-05 | 66 | 12 | 4 | HP:0010841 | |
| HumanPheno | Impulsivity | 1.34e-05 | 149 | 12 | 5 | HP:0100710 | |
| HumanPheno | Focal hemiclonic seizure | 2.23e-05 | 25 | 12 | 3 | HP:0006813 | |
| HumanPheno | Simple febrile seizure | 2.83e-05 | 27 | 12 | 3 | HP:0011171 | |
| HumanPheno | Generalized clonic seizure | 5.74e-05 | 34 | 12 | 3 | HP:0011169 | |
| HumanPheno | Focal clonic seizure | 1.09e-04 | 42 | 12 | 3 | HP:0002266 | |
| HumanPheno | Cyanosis | 1.14e-04 | 117 | 12 | 4 | HP:0000961 | |
| HumanPheno | EEG with focal epileptiform discharges | 1.17e-04 | 118 | 12 | 4 | HP:0011185 | |
| HumanPheno | Feeding difficulties in infancy | 1.32e-04 | 594 | 12 | 7 | HP:0008872 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.41e-04 | 8 | 12 | 2 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.41e-04 | 8 | 12 | 2 | HP:0200048 | |
| HumanPheno | Focal impaired awareness seizure | 1.51e-04 | 126 | 12 | 4 | HP:0002384 | |
| HumanPheno | Sudden unexpected death in epilepsy | 2.27e-04 | 10 | 12 | 2 | HP:0033258 | |
| HumanPheno | EEG with generalized epileptiform discharges | 2.35e-04 | 270 | 12 | 5 | HP:0011198 | |
| HumanPheno | Pes valgus | 2.58e-04 | 56 | 12 | 3 | HP:0008081 | |
| HumanPheno | Limited neck range of motion | 2.77e-04 | 11 | 12 | 2 | HP:0000466 | |
| HumanPheno | Epilepsia partialis continua | 3.31e-04 | 12 | 12 | 2 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 3.31e-04 | 12 | 12 | 2 | HP:0032898 | |
| HumanPheno | Compulsive behaviors | 3.63e-04 | 158 | 12 | 4 | HP:0000722 | |
| HumanPheno | Generalized tonic seizure | 3.84e-04 | 64 | 12 | 3 | HP:0010818 | |
| HumanPheno | Drooling | 3.90e-04 | 161 | 12 | 4 | HP:0002307 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 3.91e-04 | 13 | 12 | 2 | HP:0007058 | |
| HumanPheno | Excessive salivation | 4.81e-04 | 170 | 12 | 4 | HP:0003781 | |
| HumanPheno | Interictal epileptiform activity | 5.13e-04 | 319 | 12 | 5 | HP:0011182 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 5.25e-04 | 15 | 12 | 2 | HP:0007207 | |
| HumanPheno | Facial tics | 5.25e-04 | 15 | 12 | 2 | HP:0011468 | |
| HumanPheno | Interictal EEG abnormality | 5.59e-04 | 325 | 12 | 5 | HP:0025373 | |
| HumanPheno | Dysgenesis of the hippocampus | 5.99e-04 | 16 | 12 | 2 | HP:0025101 | |
| HumanPheno | Hypsarrhythmia | 6.63e-04 | 185 | 12 | 4 | HP:0002521 | |
| HumanPheno | Atypical absence status epilepticus | 6.78e-04 | 17 | 12 | 2 | HP:0011151 | |
| HumanPheno | Focal motor status epilepticus | 6.78e-04 | 17 | 12 | 2 | HP:0032663 | |
| HumanPheno | Focal-onset seizure | 7.47e-04 | 346 | 12 | 5 | HP:0007359 | |
| HumanPheno | Visually-induced seizure | 7.62e-04 | 18 | 12 | 2 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 7.62e-04 | 18 | 12 | 2 | HP:0032860 | |
| HumanPheno | EEG abnormality | 7.89e-04 | 548 | 12 | 6 | HP:0002353 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 9.44e-04 | 20 | 12 | 2 | HP:0032671 | |
| HumanPheno | EEG with spike-wave complexes | 9.79e-04 | 88 | 12 | 3 | HP:0010850 | |
| HumanPheno | EEG with abnormally slow frequencies | 9.79e-04 | 88 | 12 | 3 | HP:0011203 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 9.92e-04 | 368 | 12 | 5 | HP:0031432 | |
| HumanPheno | Status epilepticus | 1.01e-03 | 207 | 12 | 4 | HP:0002133 | |
| HumanPheno | Myoclonus | 1.03e-03 | 371 | 12 | 5 | HP:0001336 | |
| HumanPheno | Talipes valgus | 1.04e-03 | 21 | 12 | 2 | HP:0004684 | |
| HumanPheno | Perseverative thought | 1.11e-03 | 377 | 12 | 5 | HP:0030223 | |
| HumanPheno | Focal sensory seizure | 1.14e-03 | 22 | 12 | 2 | HP:0011157 | |
| HumanPheno | Reflex seizure | 1.14e-03 | 22 | 12 | 2 | HP:0020207 | |
| HumanPheno | Rigidity | 1.15e-03 | 214 | 12 | 4 | HP:0002063 | |
| HumanPheno | Abnormality of salivation | 1.17e-03 | 215 | 12 | 4 | HP:0100755 | |
| HumanPheno | Disordered formal thought process | 1.23e-03 | 386 | 12 | 5 | HP:0025769 | |
| HumanPheno | Tibial torsion | 1.25e-03 | 23 | 12 | 2 | HP:0100694 | |
| HumanPheno | Intellectual disability, borderline | 1.48e-03 | 25 | 12 | 2 | HP:0006889 | |
| HumanPheno | Epileptic aura | 1.48e-03 | 25 | 12 | 2 | HP:0033348 | |
| HumanPheno | Feeding difficulties | 1.51e-03 | 1168 | 12 | 8 | HP:0011968 | |
| HumanPheno | Abnormal thought pattern | 1.52e-03 | 404 | 12 | 5 | HP:5200269 | |
| HumanPheno | Limited knee extension | 1.73e-03 | 27 | 12 | 2 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 1.73e-03 | 27 | 12 | 2 | HP:0031475 | |
| HumanPheno | Tremor | 1.80e-03 | 639 | 12 | 6 | HP:0001337 | |
| HumanPheno | Focal aware seizure | 1.86e-03 | 28 | 12 | 2 | HP:0002349 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 1.99e-03 | 29 | 12 | 2 | HP:0032658 | |
| HumanPheno | Reduced vital capacity | 1.99e-03 | 29 | 12 | 2 | HP:0002792 | |
| HumanPheno | Dialeptic seizure | 2.08e-03 | 251 | 12 | 4 | HP:0011146 | |
| HumanPheno | Dermatological manifestations of systemic disorders | 2.12e-03 | 435 | 12 | 5 | HP:0001005 | |
| HumanPheno | Abnormal tongue physiology | 2.13e-03 | 115 | 12 | 3 | HP:0030810 | |
| HumanPheno | Progressive gait ataxia | 2.13e-03 | 30 | 12 | 2 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 2.13e-03 | 30 | 12 | 2 | HP:0001329 | |
| HumanPheno | Abnormal nervous system electrophysiology | 2.14e-03 | 924 | 12 | 7 | HP:0001311 | |
| HumanPheno | Developmental regression | 2.23e-03 | 440 | 12 | 5 | HP:0002376 | |
| HumanPheno | Epileptic encephalopathy | 2.34e-03 | 119 | 12 | 3 | HP:0200134 | |
| HumanPheno | Cogwheel rigidity | 2.43e-03 | 32 | 12 | 2 | HP:0002396 | |
| HumanPheno | Autistic behavior | 2.46e-03 | 678 | 12 | 6 | HP:0000729 | |
| HumanPheno | Choreoathetosis | 2.58e-03 | 123 | 12 | 3 | HP:0001266 | |
| HumanPheno | Obsessive-compulsive trait | 2.58e-03 | 33 | 12 | 2 | HP:0008770 | |
| HumanPheno | Abnormality of temperature sensation | 2.74e-03 | 34 | 12 | 2 | HP:0100772 | |
| HumanPheno | Impaired temperature sensation | 2.74e-03 | 34 | 12 | 2 | HP:0010829 | |
| HumanPheno | Calcaneovalgus deformity | 2.74e-03 | 34 | 12 | 2 | HP:0001848 | |
| HumanPheno | Edema | 2.89e-03 | 699 | 12 | 6 | HP:0000969 | |
| HumanPheno | Deformed tarsal bones | 2.90e-03 | 35 | 12 | 2 | HP:0008119 | |
| HumanPheno | Limitation of knee mobility | 2.90e-03 | 35 | 12 | 2 | HP:0010501 | |
| HumanPheno | Recurrent maladaptive behavior | 3.05e-03 | 1293 | 12 | 8 | HP:5200241 | |
| HumanPheno | Limitation of neck motion | 3.07e-03 | 36 | 12 | 2 | HP:0005986 | |
| MousePheno | akinesia | 5.80e-06 | 21 | 24 | 3 | MP:0002690 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 2.19e-05 | 1269 | 24 | 10 | MP:0011111 | |
| Domain | Na_channel_asu | 3.14e-12 | 10 | 33 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 3.14e-12 | 10 | 33 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 3.14e-12 | 10 | 33 | 5 | PF06512 | |
| Domain | Na_trans_cytopl | 1.21e-10 | 6 | 33 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 1.21e-10 | 6 | 33 | 4 | IPR024583 | |
| Domain | Channel_four-helix_dom | 4.92e-08 | 57 | 33 | 5 | IPR027359 | |
| Domain | - | 4.92e-08 | 57 | 33 | 5 | 1.20.120.350 | |
| Domain | IQ | 1.50e-07 | 71 | 33 | 5 | PF00612 | |
| Domain | IQ | 2.92e-07 | 81 | 33 | 5 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 4.95e-07 | 90 | 33 | 5 | IPR000048 | |
| Domain | IQ | 5.84e-07 | 93 | 33 | 5 | PS50096 | |
| Domain | Ion_trans_dom | 1.61e-06 | 114 | 33 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.61e-06 | 114 | 33 | 5 | PF00520 | |
| Domain | EF-hand-dom_pair | 1.38e-04 | 287 | 33 | 5 | IPR011992 | |
| Domain | PNMA | 1.65e-04 | 11 | 33 | 2 | PF14893 | |
| Domain | PNMA | 1.65e-04 | 11 | 33 | 2 | IPR026523 | |
| Domain | Actinin_actin-bd_CS | 7.48e-04 | 23 | 33 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 7.48e-04 | 23 | 33 | 2 | PS00020 | |
| Domain | ACTININ_1 | 7.48e-04 | 23 | 33 | 2 | PS00019 | |
| Domain | Spectrin | 7.48e-04 | 23 | 33 | 2 | PF00435 | |
| Domain | Spectrin_repeat | 1.19e-03 | 29 | 33 | 2 | IPR002017 | |
| Domain | ARM-like | 1.26e-03 | 270 | 33 | 4 | IPR011989 | |
| Domain | Spectrin/alpha-actinin | 1.45e-03 | 32 | 33 | 2 | IPR018159 | |
| Domain | SPEC | 1.45e-03 | 32 | 33 | 2 | SM00150 | |
| Domain | ARM-type_fold | 2.88e-03 | 339 | 33 | 4 | IPR016024 | |
| Domain | CH | 5.87e-03 | 65 | 33 | 2 | SM00033 | |
| Domain | CH | 6.78e-03 | 70 | 33 | 2 | PF00307 | |
| Domain | HEAT_REPEAT | 6.78e-03 | 70 | 33 | 2 | PS50077 | |
| Domain | - | 6.95e-03 | 222 | 33 | 3 | 1.25.10.10 | |
| Domain | - | 6.97e-03 | 71 | 33 | 2 | 1.10.418.10 | |
| Domain | CH | 7.36e-03 | 73 | 33 | 2 | PS50021 | |
| Domain | CH-domain | 7.75e-03 | 75 | 33 | 2 | IPR001715 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 8.86e-12 | 31 | 24 | 6 | M877 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 8.84e-10 | 121 | 24 | 7 | M872 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.79e-09 | 32 | 24 | 5 | M27455 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 8.98e-07 | 203 | 24 | 6 | M5485 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.81e-06 | 367 | 24 | 7 | M48346 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.28e-06 | 130 | 24 | 5 | M27454 | |
| Pathway | WP_DRAVET_SYNDROME | 1.38e-05 | 28 | 24 | 3 | M45519 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.42e-05 | 575 | 24 | 7 | M29853 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 6.88e-04 | 23 | 24 | 2 | M913 | |
| Pubmed | 7.04e-14 | 9 | 33 | 5 | 16382098 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.01e-11 | 6 | 33 | 4 | 23652591 | |
| Pubmed | 8.43e-11 | 9 | 33 | 4 | 15746173 | ||
| Pubmed | 4.77e-10 | 13 | 33 | 4 | 15123669 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 33895391 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 17537961 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 35031483 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 29578003 | ||
| Pubmed | 7.77e-09 | 5 | 33 | 3 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 7.77e-09 | 5 | 33 | 3 | 22875929 | |
| Pubmed | 7.77e-09 | 5 | 33 | 3 | 17724025 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.70e-07 | 12 | 33 | 3 | 30175250 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.06e-07 | 139 | 33 | 5 | 16985003 | |
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 8.73e-07 | 2 | 33 | 2 | 37901435 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 33411788 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 18079277 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 8.73e-07 | 2 | 33 | 2 | 26410685 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 31943325 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 27690330 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 8.73e-07 | 2 | 33 | 2 | 27174182 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 8.73e-07 | 2 | 33 | 2 | 23965409 | |
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 8.73e-07 | 2 | 33 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 8.73e-07 | 2 | 33 | 2 | 25172946 | |
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 8.73e-07 | 2 | 33 | 2 | 37665666 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 17881658 | ||
| Pubmed | Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. | 2.62e-06 | 3 | 33 | 2 | 24704313 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19284629 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 12610651 | ||
| Pubmed | The sorting receptor Rer1 controls Purkinje cell function via voltage gated sodium channels. | 2.62e-06 | 3 | 33 | 2 | 28117367 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17928448 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23859570 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19699781 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 14973256 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18784617 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17544618 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 26182346 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 32845893 | ||
| Pubmed | De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy. | 2.62e-06 | 3 | 33 | 2 | 31054517 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 20038812 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 28518218 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 27816501 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 15302875 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 21156207 | ||
| Pubmed | Models for discovery of targeted therapy in genetic epileptic encephalopathies. | 5.23e-06 | 4 | 33 | 2 | 28742937 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 35801810 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 22260870 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 5.23e-06 | 4 | 33 | 2 | 8974318 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 6.60e-06 | 497 | 33 | 6 | 36774506 | |
| Pubmed | Molecular determinants of voltage-gated sodium channel regulation by the Nedd4/Nedd4-like proteins. | 8.72e-06 | 5 | 33 | 2 | 15548568 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 1679748 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 24337656 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 16029194 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 12149647 | ||
| Pubmed | The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease. | 1.31e-05 | 6 | 33 | 2 | 16214224 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 23711479 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 9143501 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 11046148 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 15272007 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 1.83e-05 | 7 | 33 | 2 | 24440715 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 1.83e-05 | 7 | 33 | 2 | 25818041 | |
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 25101983 | ||
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 9412493 | ||
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 3.13e-05 | 9 | 33 | 2 | 8854872 | |
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 3.13e-05 | 9 | 33 | 2 | 17884088 | |
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 8199405 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 16884701 | ||
| Pubmed | Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. | 4.26e-05 | 71 | 33 | 3 | 8751373 | |
| Pubmed | 5.73e-05 | 12 | 33 | 2 | 8169823 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 9.10e-05 | 15 | 33 | 2 | 9726281 | |
| Pubmed | 1.99e-04 | 22 | 33 | 2 | 26542012 | ||
| Pubmed | Transcriptional profiling of sequentially generated septal neuron fates. | 2.80e-04 | 26 | 33 | 2 | 34851821 | |
| Pubmed | Quantitative-trait loci analysis of cocaine-related behaviours and neurochemistry. | 2.80e-04 | 26 | 33 | 2 | 10591541 | |
| Pubmed | Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development. | 3.25e-04 | 28 | 33 | 2 | 37846569 | |
| Pubmed | 3.74e-04 | 30 | 33 | 2 | 24472646 | ||
| Pubmed | 5.68e-04 | 405 | 33 | 4 | 38187761 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 6.31e-04 | 742 | 33 | 5 | 26871637 | |
| Pubmed | Dynamic spatiotemporal gene expression in embryonic mouse thalamus. | 7.00e-04 | 41 | 33 | 2 | 21192082 | |
| Pubmed | 8.43e-04 | 45 | 33 | 2 | 25979088 | ||
| Interaction | SCN5A interactions | 1.01e-06 | 47 | 33 | 4 | int:SCN5A | |
| Interaction | SCN11A interactions | 1.80e-06 | 15 | 33 | 3 | int:SCN11A | |
| Cytoband | 2q24 | 2.74e-05 | 11 | 33 | 2 | 2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.06e-04 | 127 | 33 | 3 | chr2q24 | |
| Cytoband | 4p15.2 | 1.87e-04 | 28 | 33 | 2 | 4p15.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 3.11e-04 | 183 | 33 | 3 | chr16q22 | |
| Cytoband | 16q22.1 | 2.86e-03 | 110 | 33 | 2 | 16q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p15 | 4.27e-03 | 135 | 33 | 2 | chr4p15 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.15e-13 | 9 | 25 | 5 | 1203 | |
| GeneFamily | Paraneoplastic Ma antigens | 1.00e-04 | 11 | 25 | 2 | 671 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.97e-07 | 193 | 33 | 5 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.97e-07 | 193 | 33 | 5 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | LAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class | 3.37e-07 | 198 | 33 | 5 | ba64b1c95dfaa995045239d412e725596f6c482e | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.86e-06 | 178 | 33 | 4 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.67e-06 | 182 | 33 | 4 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.88e-06 | 183 | 33 | 4 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.03e-05 | 185 | 33 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.03e-05 | 185 | 33 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 186 | 33 | 4 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 186 | 33 | 4 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-05 | 188 | 33 | 4 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | Neuroendocrine-neuroendo-2-Calca|World / Class top | 1.12e-05 | 189 | 33 | 4 | 6baa9a74560121cc008bb8fa9b2b7a335b3aeee0 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-05 | 192 | 33 | 4 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-05 | 192 | 33 | 4 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | Neuroendocrine|World / Class top | 1.19e-05 | 192 | 33 | 4 | 0199da3ef9ddb6673e9aa41f346f374838aec182 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 194 | 33 | 4 | bc03d0f8dca9f4ba10db2f2274293f8b119e8951 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-05 | 195 | 33 | 4 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-05 | 195 | 33 | 4 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 196 | 33 | 4 | ff627244d7f5fd6a2ec009dae32d3509f0e2d95e | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.37e-05 | 199 | 33 | 4 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-05 | 199 | 33 | 4 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-05 | 199 | 33 | 4 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 33 | 4 | 1587d24b19f5bb64a3b6cc1df87c7c472cf41672 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 33 | 4 | a9c2041e54899cb8ccc026758647f3ae3ca457dd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.40e-05 | 200 | 33 | 4 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.40e-05 | 200 | 33 | 4 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 146 | 33 | 3 | e887e9de895fd453faa703997ef372cc6410fc49 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-04 | 157 | 33 | 3 | 19c0599a669803c4db1f174de1ce755e562a50a3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 158 | 33 | 3 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 158 | 33 | 3 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.27e-04 | 161 | 33 | 3 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 161 | 33 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 161 | 33 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 161 | 33 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-04 | 162 | 33 | 3 | 08b7f06580d516307516d5475a5dae0fa040f1a4 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-04 | 162 | 33 | 3 | 1fda21a303a08aff6f97819cd8766cd18784d8bc | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-04 | 162 | 33 | 3 | fc313fb2c55957faa8c9ca4023b3fce63527c267 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-04 | 162 | 33 | 3 | 002fac3c5c3030950f9eb9e887d59902586d8452 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-04 | 162 | 33 | 3 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 164 | 33 | 3 | 07d9252b267cb61c6050fbfa5b440aef1349f673 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 164 | 33 | 3 | 7c016236f0cea38195c1373ebbd2c0b2b2ec81ad | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.48e-04 | 166 | 33 | 3 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.57e-04 | 168 | 33 | 3 | 84977db9d71e59208727885320cc18d80d064380 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-04 | 168 | 33 | 3 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 168 | 33 | 3 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-04 | 168 | 33 | 3 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-04 | 169 | 33 | 3 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 2.61e-04 | 169 | 33 | 3 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-04 | 169 | 33 | 3 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-04 | 170 | 33 | 3 | 35e3945d8a540a3e2cec1b559316265aaad023d1 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-04 | 170 | 33 | 3 | 0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-04 | 170 | 33 | 3 | 0b5ddc7d452db0a389927a367914f7d257703f7e | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-04 | 171 | 33 | 3 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-04 | 171 | 33 | 3 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-04 | 171 | 33 | 3 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-04 | 171 | 33 | 3 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-04 | 171 | 33 | 3 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-04 | 171 | 33 | 3 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.80e-04 | 173 | 33 | 3 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-04 | 173 | 33 | 3 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-04 | 174 | 33 | 3 | 9f114e61458659005b6d0b4aa30a7a059e7aa5c6 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.90e-04 | 175 | 33 | 3 | 9941c35601134d88d1b3249c81f8b43a8fc61610 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-04 | 175 | 33 | 3 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-HSC-MPP|lymph-node_spleen / Manually curated celltypes from each tissue | 2.95e-04 | 176 | 33 | 3 | 32ed5623b8809b9f1aaf7a42dff9807d9376e9c2 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.95e-04 | 176 | 33 | 3 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.04e-04 | 178 | 33 | 3 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.09e-04 | 179 | 33 | 3 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 180 | 33 | 3 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 180 | 33 | 3 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-04 | 181 | 33 | 3 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-04 | 181 | 33 | 3 | 2392af8c7f040c23a7d416c2e37419954970c8f4 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-04 | 181 | 33 | 3 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-04 | 181 | 33 | 3 | 4a225d9a6d113396c6b1d0a839bb4ca9c339a260 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-04 | 181 | 33 | 3 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.25e-04 | 182 | 33 | 3 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.25e-04 | 182 | 33 | 3 | 63c3b63315276b66667d49fab09661ac320e7a36 | |
| ToppCell | B_cell_maturation-immature_B_cell|World / Lineage and Cell class | 3.25e-04 | 182 | 33 | 3 | 2c7c51ebc4125d8a33454ffee0b143579ce5e451 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.25e-04 | 182 | 33 | 3 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | (6)_Endothelial-F_(Lymphatics)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.35e-04 | 184 | 33 | 3 | 03ea613e00b45c81b752c14505a0538d698f551e | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 3.35e-04 | 184 | 33 | 3 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.41e-04 | 185 | 33 | 3 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.41e-04 | 185 | 33 | 3 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 3.41e-04 | 185 | 33 | 3 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | Endoth-Lymph|World / shred by cell class for parenchyma | 3.41e-04 | 185 | 33 | 3 | 97a6c4cd00684d4085d36ef32f7dbb99563ed357 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-04 | 186 | 33 | 3 | 7a8da2ad140bea3207bd868212cc5e201d586772 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-04 | 186 | 33 | 3 | dc394034929c6b10ae0e1c1a028cc3d4ce873298 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.46e-04 | 186 | 33 | 3 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-04 | 186 | 33 | 3 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 186 | 33 | 3 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.46e-04 | 186 | 33 | 3 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-04 | 186 | 33 | 3 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | 51336037dfd4bbe9fe9ce1e5b6b92d037156690c | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | 43e35ec995afd8780893de42ac4ee466794991d7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.52e-04 | 187 | 33 | 3 | 98477ba04a42a8da80a72f41a182429f46283595 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 187 | 33 | 3 | 25efb82afe863a853ecdd781ad89026c993aaa67 | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.52e-04 | 187 | 33 | 3 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | B_cell_maturation-immature_B_cell|B_cell_maturation / Lineage and Cell class | 3.52e-04 | 187 | 33 | 3 | 9afbb21654c8eb6f9c6a7cbd0664d890282ddceb | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | 8ca9481d661626f6f0e1b61eb142b051192a9208 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 188 | 33 | 3 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-04 | 188 | 33 | 3 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 2.77e-09 | 3 | 33 | 3 | ctd:C561228 | |
| Drug | Zonisamide | 8.59e-09 | 17 | 33 | 4 | DB00909 | |
| Drug | APETx1, Anthopleura elegantissima | 5.53e-08 | 6 | 33 | 3 | ctd:C475726 | |
| Drug | Scorpion Venoms | 2.23e-06 | 18 | 33 | 3 | ctd:D012604 | |
| Drug | diprafenone | 2.65e-06 | 19 | 33 | 3 | CID000071249 | |
| Drug | AC1NT1AF | 6.24e-06 | 25 | 33 | 3 | CID005322157 | |
| Drug | Pirmenolum | 7.05e-06 | 26 | 33 | 3 | CID000004853 | |
| Drug | PbTx-1 | 7.92e-06 | 27 | 33 | 3 | CID006437089 | |
| Drug | AC1L1MOZ | 7.92e-06 | 27 | 33 | 3 | CID000031958 | |
| Drug | nefopam | 7.92e-06 | 27 | 33 | 3 | CID000004450 | |
| Drug | paraben | 8.87e-06 | 28 | 33 | 3 | CID000007175 | |
| Drug | tocainide | 1.10e-05 | 30 | 33 | 3 | CID000038945 | |
| Drug | oxcarbazepine | 1.10e-05 | 30 | 33 | 3 | CID000034312 | |
| Drug | NSC93767 | 1.34e-05 | 32 | 33 | 3 | CID000005658 | |
| Drug | 5-hydroxypropafenone | 1.61e-05 | 34 | 33 | 3 | CID000107927 | |
| Drug | ciguatoxin | 1.76e-05 | 35 | 33 | 3 | CID005311333 | |
| Drug | benzocaine | 2.08e-05 | 37 | 33 | 3 | CID000002337 | |
| Drug | aprindine | 2.26e-05 | 38 | 33 | 3 | CID000002218 | |
| Drug | Tetrodotoxin | 2.64e-05 | 40 | 33 | 3 | ctd:D013779 | |
| Drug | S-ropivacaine | 2.64e-05 | 40 | 33 | 3 | CID000071273 | |
| Drug | pilsicainide | 4.04e-05 | 46 | 33 | 3 | CID000004820 | |
| Drug | spiradoline | 4.04e-05 | 46 | 33 | 3 | CID000005620 | |
| Drug | norepinephrine sulfate | 4.26e-05 | 7 | 33 | 2 | CID000123747 | |
| Drug | indoxacarb | 4.88e-05 | 49 | 33 | 3 | CID000107720 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 5.67e-05 | 8 | 33 | 2 | ctd:C489827 | |
| Drug | decamethrin | 5.75e-05 | 146 | 33 | 4 | ctd:C017180 | |
| Drug | salbutamol | 5.75e-05 | 146 | 33 | 4 | CID000002083 | |
| Drug | AC1NSN3X | 6.54e-05 | 54 | 33 | 3 | CID005366189 | |
| Drug | orphenadrine | 7.30e-05 | 56 | 33 | 3 | CID000004601 | |
| Drug | triamterene | 8.11e-05 | 58 | 33 | 3 | CID000005546 | |
| Drug | methylglucamine | 9.90e-05 | 62 | 33 | 3 | CID000004049 | |
| Drug | zonisamide | 9.90e-05 | 62 | 33 | 3 | CID000005734 | |
| Drug | RH-3421 | 1.11e-04 | 11 | 33 | 2 | CID000108039 | |
| Drug | chloroacetylajmaline | 1.11e-04 | 11 | 33 | 2 | CID000038681 | |
| Drug | saxitoxin | 1.14e-04 | 65 | 33 | 3 | CID000037165 | |
| Drug | AC1L1CQC | 1.14e-04 | 65 | 33 | 3 | CID000002012 | |
| Drug | resiniferatoxin | 1.19e-04 | 66 | 33 | 3 | CID000104826 | |
| Drug | mexiletine | 1.19e-04 | 66 | 33 | 3 | CID000004178 | |
| Drug | disopyramide | 1.19e-04 | 66 | 33 | 3 | CID000003114 | |
| Drug | dibucaine | 1.30e-04 | 68 | 33 | 3 | CID000003025 | |
| Drug | strychnine HCl | 1.32e-04 | 181 | 33 | 4 | CID000005304 | |
| Drug | Ro 22-9194 | 1.33e-04 | 12 | 33 | 2 | CID000129209 | |
| Drug | GBR 12909 | 1.36e-04 | 69 | 33 | 3 | CID000003455 | |
| Drug | T2755 | 1.48e-04 | 71 | 33 | 3 | CID000005514 | |
| Drug | synthetic pyrethrins | 1.48e-04 | 71 | 33 | 3 | CID000002982 | |
| Drug | flecainide | 1.48e-04 | 71 | 33 | 3 | CID000003355 | |
| Drug | ofloxacin | 1.55e-04 | 72 | 33 | 3 | CID000004583 | |
| Drug | CID6432355 | 1.57e-04 | 13 | 33 | 2 | CID006432355 | |
| Drug | cefditoren | 1.57e-04 | 13 | 33 | 2 | CID000444006 | |
| Drug | AC1LCJM3 | 1.57e-04 | 13 | 33 | 2 | CID000631640 | |
| Drug | procainamide | 1.59e-04 | 190 | 33 | 4 | CID000004913 | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.62e-04 | 191 | 33 | 4 | 3803_DN | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.66e-04 | 192 | 33 | 4 | 4356_UP | |
| Drug | 1, 3-diallylurea | 1.68e-04 | 74 | 33 | 3 | CID000074537 | |
| Drug | imide | 1.68e-04 | 74 | 33 | 3 | CID000443040 | |
| Drug | isofagomine | 1.74e-04 | 75 | 33 | 3 | CID000447607 | |
| Drug | diphenhydramine | 1.74e-04 | 75 | 33 | 3 | CID000003100 | |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | 1.76e-04 | 195 | 33 | 4 | 311_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 1.76e-04 | 195 | 33 | 4 | 3755_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.79e-04 | 196 | 33 | 4 | 4421_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.79e-04 | 196 | 33 | 4 | 5757_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.79e-04 | 196 | 33 | 4 | 5765_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 5343_DN | |
| Drug | lorcainide | 1.83e-04 | 14 | 33 | 2 | CID000042883 | |
| Drug | octylguanidine | 1.83e-04 | 14 | 33 | 2 | CID000030621 | |
| Drug | AG-028671 [847803-03-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 6557_DN | |
| Drug | ST021200; Down 200; 10uM; MCF7; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 7488_DN | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; PC3; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 6323_UP | |
| Drug | Suprofen [40828-46-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 3343_UP | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 4362_UP | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 6295_UP | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 4819_UP | |
| Drug | Arecoline hydrobromide [300-08-3]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 5423_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 1.94e-04 | 200 | 33 | 4 | 5931_DN | |
| Drug | trimethyloxonium | 2.11e-04 | 15 | 33 | 2 | CID000093245 | |
| Drug | AC1L1W4O | 2.11e-04 | 15 | 33 | 2 | CID000036625 | |
| Drug | bupropion | 2.19e-04 | 81 | 33 | 3 | CID000000444 | |
| Drug | Sodium | 2.44e-04 | 84 | 33 | 3 | ctd:D012964 | |
| Drug | articaine | 2.73e-04 | 17 | 33 | 2 | CID000032169 | |
| Drug | lifarizine | 2.73e-04 | 17 | 33 | 2 | CID000071336 | |
| Drug | S 254 | 2.73e-04 | 17 | 33 | 2 | CID000029642 | |
| Drug | phenytoin | 2.74e-04 | 219 | 33 | 4 | CID000001775 | |
| Drug | pentobarbital | 2.98e-04 | 224 | 33 | 4 | CID000004737 | |
| Drug | moricizine | 3.07e-04 | 18 | 33 | 2 | CID000034632 | |
| Drug | propafenone | 3.84e-04 | 98 | 33 | 3 | CID000004932 | |
| Drug | trimethoprim | 3.96e-04 | 99 | 33 | 3 | CID000005578 | |
| Drug | isradipine | 4.08e-04 | 100 | 33 | 3 | CID000003784 | |
| Drug | ciprofloxacin | 4.20e-04 | 101 | 33 | 3 | CID000002764 | |
| Drug | BDF 9148 | 4.20e-04 | 21 | 33 | 2 | CID000123765 | |
| Drug | grepafloxacin | 5.06e-04 | 23 | 33 | 2 | CID000072474 | |
| Drug | Multicide | 5.99e-04 | 25 | 33 | 2 | CID000024365 | |
| Drug | batrachotoxinin A 20-alpha-benzoate | 5.99e-04 | 25 | 33 | 2 | CID005485225 | |
| Drug | lamotrigine | 6.29e-04 | 116 | 33 | 3 | CID000003878 | |
| Drug | PbTx-2 | 6.48e-04 | 26 | 33 | 2 | CID000002432 | |
| Drug | phenamil | 6.48e-04 | 26 | 33 | 2 | CID000004755 | |
| Drug | ethionamide | 6.48e-04 | 26 | 33 | 2 | CID002761171 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.71e-13 | 10 | 32 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.71e-13 | 10 | 32 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 8.51e-13 | 12 | 32 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 8.63e-07 | 163 | 32 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 1.14e-06 | 2 | 32 | 2 | C4551549 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.76e-06 | 22 | 32 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | B Virus Infection | 3.42e-06 | 3 | 32 | 2 | C0037140 | |
| Disease | Postherpetic neuralgia | 3.42e-06 | 3 | 32 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 3.42e-06 | 3 | 32 | 2 | C0019372 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 3.18e-05 | 8 | 32 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 3.18e-05 | 8 | 32 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 3.18e-05 | 8 | 32 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 3.18e-05 | 8 | 32 | 2 | C0438414 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 3.18e-05 | 8 | 32 | 2 | C0751120 | |
| Disease | Myoclonic Absence Epilepsy | 3.18e-05 | 8 | 32 | 2 | C0393703 | |
| Disease | Myoclonic Epilepsy | 4.08e-05 | 9 | 32 | 2 | C0014550 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 4.08e-05 | 9 | 32 | 2 | C3502809 | |
| Disease | Epilepsy, Myoclonic, Infantile | 5.10e-05 | 10 | 32 | 2 | C0917800 | |
| Disease | Myoclonic Astatic Epilepsy | 6.23e-05 | 11 | 32 | 2 | C0393702 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 8.82e-05 | 13 | 32 | 2 | C0751122 | |
| Disease | Neurodevelopmental Disorders | 1.41e-04 | 93 | 32 | 3 | C1535926 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 1.53e-04 | 17 | 32 | 2 | C1839839 | |
| Disease | Epilepsy | 2.25e-04 | 109 | 32 | 3 | C0014544 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GDSMELEIWCLEMNE | 91 | O75143 | |
| WMEGAMEDLQDMFIV | 531 | P35609 | |
| CMCEAWEEILMQMDS | 271 | Q9UJX5 | |
| WMPESEMEVMELELG | 141 | Q7Z6K5 | |
| CTELETVMMDWLGKM | 111 | P20711 | |
| ATEEEMWECLNALGM | 216 | A8MXT2 | |
| IGICEAESWMLVMEM | 436 | P43405 | |
| AESWMLVMEMAELGP | 441 | P43405 | |
| MDQLLGNMIEMWVDR | 821 | Q9UI26 | |
| GNMIEMWVDRMDNIT | 826 | Q9UI26 | |
| PVCWDLMDQTGEMRM | 216 | Q6IB77 | |
| MCAVIDEEEMMEWTS | 1666 | Q8IVV2 | |
| MEGCMGEESFQMWEL | 1 | P48681 | |
| GESMAQRMVWVDLEM | 36 | Q9Y3B8 | |
| MWQKEEMGISCELLE | 686 | Q13797 | |
| EWTLMDLDMELSLMQ | 406 | Q9ULV5 | |
| WGLLDTMEQMSREDM | 356 | Q6UWW8 | |
| MAMTLLEDWCRGMDV | 1 | Q8ND90 | |
| MELLQDMSGIMKWSE | 246 | Q9BYJ4 | |
| GLAWMADAMEMMILS | 91 | Q8N4V2 | |
| MWDCMEVAGQAMCLT | 766 | P35499 | |
| MREELSAAPMDWMQE | 281 | Q7L2K0 | |
| MENCMVLEWDHIEMN | 251 | Q8N0V4 | |
| TMWDCMEVAGQAMCL | 931 | Q15858 | |
| ETMWDCMEVAGQTMC | 946 | Q9NY46 | |
| MMWDNVNAEDCQEMF | 876 | Q7Z745 | |
| MWDCMEVAGQAMCLT | 956 | P35498 | |
| MDWMDEMKVLVLSQD | 541 | Q01082 | |
| MALTLLEDWCKGMDM | 1 | Q96PV4 | |
| ELMLCGMQEIDMSDW | 746 | O00308 | |
| LDKWMLEMTEGPCRM | 2366 | Q8IZQ1 | |
| EMVIEVGEMVQDWAM | 691 | Q9H6E5 | |
| MWDCMEVAGQAMCLI | 941 | Q9UQD0 | |
| MVSQLEAEEKLWMME | 71 | Q86WZ6 | |
| GCFKDWMVSMIMDRE | 86 | P0CL85 |